Combination Therapy of SORA and FGF21 in Hepatocellular Carcinoma
The author argues that combining SORA and FGF21 can enhance the sensitivity of hepatocellular carcinoma cells to treatment under hypoxic conditions, potentially improving outcomes for patients.